Yuqin Sun

State Key Laboratory Of Pathogenesis
Ueruemqi, 830011, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

Correction: Blockade of the CCL2-CCR2 axis attenuates fibrosis and parasite load in vesicular echinococcosis by inhibiting the PI3K-AKT pathway that regulates angiogenesis and hepatic stellate cell apoptosis.

Correction: Blockade of the CCL2-CCR2 axis attenuates fibrosis and parasite load in vesicular echinococcosis by inhibiting the PI3K-AKT pathway that regulates angiogenesis and hepatic stellate cell apoptosis.

Journal: Parasites & vectors

Published: August 04, 2026

Corrigendum to "Identification and exploration of a new M2 macrophage marker MTLN in alveolar echinococcosis" [Int. Immunopharmacol. 131 (2024) 111808].

Corrigendum to "Identification and exploration of a new M2 macrophage marker MTLN in alveolar echinococcosis" [Int. Immunopharmacol. 131 (2024) 111808].

Journal: International immunopharmacology

Published: June 30, 2026

Corrigendum to "CCL17 and CCL19 are markers of disease progression in alveolar echinococcosis" [Cytokine 181 (2024) 156669].

Corrigendum to "CCL17 and CCL19 are markers of disease progression in alveolar echinococcosis" [Cytokine 181 (2024) 156669].

Journal: Cytokine

Published: June 12, 2026

Compound Biejia-Ruangan tablets activate the STING-TBK1 pathway to alleviate hepatic fibrosis in alveolar echinococcosis.

Compound Biejia-Ruangan tablets activate the STING-TBK1 pathway to alleviate hepatic fibrosis in alveolar echinococcosis.

Journal: Microbiology spectrum

Published: April 21, 2026

Blockade of the CCL2-CCR2 axis attenuates fibrosis and parasite load in vesicular echinococcosis by inhibiting the PI3K-AKT pathway that regulates angiogenesis and hepatic stellate cell apoptosis.

Blockade of the CCL2-CCR2 axis attenuates fibrosis and parasite load in vesicular echinococcosis by inhibiting the PI3K-AKT pathway that regulates angiogenesis and hepatic stellate cell apoptosis.

Journal: Parasites & vectors

Published: October 28, 2025

Targeted inhibition of METTL3 reprograms alveolar echinococcosis progression: attenuating ferroptosis by downregulating ACSL4 and reversing macrophage M2 polarization.

Targeted inhibition of METTL3 reprograms alveolar echinococcosis progression: attenuating ferroptosis by downregulating ACSL4 and reversing macrophage M2 polarization.

Journal: International immunopharmacology

Published: July 22, 2025

Corrigendum to "Identification and exploration of a new M2 macrophage marker MTLN in alveolar echinococcosis" [International Immunopharmacology 131 (2024) 111808].

Corrigendum to "Identification and exploration of a new M2 macrophage marker MTLN in alveolar echinococcosis" [International Immunopharmacology 131 (2024) 111808].

Journal: International immunopharmacology

Published: May 03, 2025

CCL17 and CCL19 are markers of disease progression in alveolar echinococcosis.

CCL17 and CCL19 are markers of disease progression in alveolar echinococcosis.

Journal: Cytokine

Published: May 10, 2024

Identification and exploration of a new M2 macrophage marker MTLN in alveolar echinococcosis.

Identification and exploration of a new M2 macrophage marker MTLN in alveolar echinococcosis.

Journal: International immunopharmacology

Published: February 14, 2024

Exploration of gastric neuroendocrine carcinoma (GNEC) specific signaling pathways involved in chemoresistance via transcriptome and in vitro analysis.

Exploration of gastric neuroendocrine carcinoma (GNEC) specific signaling pathways involved in chemoresistance via transcriptome and in vitro analysis.

Journal: Computational and structural biotechnology journal

Published: July 23, 2020

Showing 1-10 of 10

Last Updated: 09/26/2026